Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

ASSESSMENT OF ANTI- HYPERGLYCAEMIC DRUG PRESCRIPTION PATTERN: A PROSPECTIVE, PHARMACOEPIDEMIOLOGIC STUDY

Pamidi Pradeep*, M.Prudhvi Kumar, Pamidi Praveen, M.Poornima Sravya,
P.Chandra Sai, M.Vinod Kumar, P.Ramya

Pharm.D Intern, Chalapathi Institute of Pharmaceutical Sciences, Acharya Nagarjuna
University, Guntur, A.P, India.

ABSTRACT

Diabetes mellitus is a chronic illness associated with significant morbidity and mortality. Diabetes treatment depends on the type and severity of the diabetes. prospective observational study, in the general medicine department of a tertiary care hospital. Ethical clearance was obtained prior to the study. Patient data was collected by using a patient data collection form and their drug use was recorded and subjected to analysis. A total of 472 patient’s data was recorded and analyzed for the prescription pattern of anti-diabetics using WHO Core Indicators. 67.37% prescriptions contained a single anti-diabetic drug whereas 32.62%prescriptions a combination of anti-diabetic drugs. Drugs were classified according to their class where metformin(41.19%) was found to be most prescribed followed by sulphonylureas. The combination therapy, Glimepiride + Metformin combination was most frequently prescribed followed by Glimipride+ Insulin.Average number of drugs per prescription was 5.5±2.9. Drugs prescribed by generic names(98.26%) was very much higher than prescribed by their brand names (1.73%).

Keywords: Diabetes mellitus; Anti-hyperglycaemic drug Prescribing Pattern, Drug utilization studies, ATC code.


[Full Text Article]